SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-012029
Filing Date
2019-08-12
Accepted
2019-08-12 06:31:25
Documents
60
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 635744
2 ex31-1.htm EX-31.1 16492
3 ex31-2.htm EX-31.2 16252
4 ex32-1.htm EX-32.1 9117
  Complete submission text file 0001493152-19-012029.txt   3851967

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ghsi-20190630.xml EX-101.INS 689393
6 XBRL SCHEMA FILE ghsi-20190630.xsd EX-101.SCH 44562
7 XBRL CALCULATION FILE ghsi-20190630_cal.xml EX-101.CAL 59975
8 XBRL DEFINITION FILE ghsi-20190630_def.xml EX-101.DEF 179529
9 XBRL LABEL FILE ghsi-20190630_lab.xml EX-101.LAB 330572
10 XBRL PRESENTATION FILE ghsi-20190630_pre.xml EX-101.PRE 261653
Mailing Address 15150 AVENUE OF SCIENCE, SUITE 200 SAN DIEGO CA 92128
Business Address 15150 AVENUE OF SCIENCE, SUITE 200 SAN DIEGO CA 92128 858-605-9055
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38861 | Film No.: 191014338
SIC: 2834 Pharmaceutical Preparations